Liquid biopsies for surveillance and monitoring treatment response of bladder cancer

Affiliations

Editorial

Sabine Riethdorf et al. Ann Transl Med. 2016 Oct.

. 2016 Oct;4(19):379.

doi: 10.21037/atm.2016.08.27.

¹ Department of Tumor Biology, University Medical Center Hamburg-Eppendorf, Hamburg, Germany.

No abstract available

Conflict of interest statement

The authors have no conflicts of interest to declare.

Genomic Alterations in Liquid Biopsies from Patients with Bladder Cancer.
Birkenkamp-Demtröder K, Nordentoft I, Christensen E, Høyer S, Reinert T, Vang S, Borre M, Agerbæk M, Jensen JB, Ørntoft TF, Dyrskjøt L. Birkenkamp-Demtröder K, et al. Eur Urol. 2016 Jul;70(1):75-82. doi: 10.1016/j.eururo.2016.01.007. Epub 2016 Jan 20. Eur Urol. 2016. PMID: 26803478

1. Torre LA, Siegel RL, Ward EM, et al. Global Cancer Incidence and Mortality Rates and Trends--An Update. Cancer Epidemiol Biomarkers Prev 2016;25:16-27. 10.1158/1055-9965.EPI-15-0578 - DOI - PubMed
1. Burger M, Catto JW, Dalbagni G, et al. Epidemiology and risk factors of urothelial bladder cancer. Eur Urol 2013;63:234-41. 10.1016/j.eururo.2012.07.033 - DOI - PubMed
1. Babjuk M, Burger M, Zigeuner R, et al. EAU guidelines on non-muscle-invasive urothelial carcinoma of the bladder: update 2013. Eur Urol 2013;64:639-53. 10.1016/j.eururo.2013.06.003 - DOI - PubMed
1. Knowles MA, Hurst CD. Molecular biology of bladder cancer: new insights into pathogenesis and clinical diversity. Nat Rev Cancer 2015;15:25-41. 10.1038/nrc3817 - DOI - PubMed
1. Bell MD, Yafi FA, Brimo F, et al. Prognostic value of urinary cytology and other biomarkers for recurrence and progression in bladder cancer: a prospective study. World J Urol 2016. [Epub ahead of print]. 10.1007/s00345-016-1795-5 - DOI - PubMed